Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Fidelity MSCI Materials Index ETF
FMAT
$622M
| $6.03M | ﹤0.01% |
+124,866
| New | +$6.21M |
|
3302
Axsome Therapeutics
AXSM
$10.4B
| $6.03M | ﹤0.01% |
51,726
+32,956
| +176% | +$3.75M |
|
3303
Southwest Gas
SWX
$6.45B
| $6.03M | ﹤0.01% |
83,978
+52,374
| +166% | +$3.88M |
|
3304
Qualys
QLYS
$6.47B
| $6.03M | ﹤0.01% |
47,874
+27,487
| +135% | +$3.72M |
|
3305
Henry Schein
HSIC
$9.98B
| $6.03M | ﹤0.01% |
88,012
+2,790
| +3% | +$206K |
|
3306
PVH
PVH
$3.49B
| $6.02M | ﹤0.01% |
93,205
+67,536
| +263% | +$5.46M |
|
3307
PUT
UGI
UGI
$8.15B
| $6.02M | ﹤0.01% |
182,000
-79,800
| -30% | -$2.53M |
|
3308
CALL
Extra Space Storage
EXR
$30.2B
| $6.01M | ﹤0.01% |
40,500
+10,600
| +35% | +$1.61M |
|
3309
PUT
Protagonist Therapeutics
PTGX
$9.34B
| $6.01M | ﹤0.01% |
124,200
+34,700
| +39% | +$1.45M |
|
3310
CALL
Vanguard Energy ETF
VDE
$10.7B
| $6.01M | ﹤0.01% |
46,300
-56,400
| -55% | -$7.12M |
|
3311
Iovance Biotherapeutics
IOVA
$3.63B
| $6M | ﹤0.01% |
1,802,193
-860,502
| -32% | -$4.44M |
|
3312
CALL
Jones Lang LaSalle
JLL
$17.4B
| $6M | ﹤0.01% |
24,200
+15,400
| +175% | +$4.05M |
|
3313
Teladoc Health
TDOC
$1.18B
| $6M | ﹤0.01% |
753,419
-188,944
| -20% | -$1.91M |
|
|
3314
CALL
Qualys
QLYS
$6.47B
| $5.99M | ﹤0.01% |
47,600
+19,600
| +70% | +$2.65M |
|
3315
Fulton Financial
FULT
$4.52B
| $5.99M | ﹤0.01% |
331,055
+222,638
| +205% | +$4.34M |
|
3316
PUT
Wabtec
WAB
$49.4B
| $5.98M | ﹤0.01% |
33,000
-43,900
| -57% | -$8.42M |
|
3317
Towne Bank
TOWN
$3.46B
| $5.98M | ﹤0.01% |
174,970
+77,390
| +79% | +$2.73M |
|
3318
PUT
Bitdeer Technologies
BTDR
$2.8B
| $5.97M | ﹤0.01% |
676,300
+151,000
| +29% | +$2.26M |
|
3319
Darling Ingredients
DAR
$10.1B
| $5.97M | ﹤0.01% |
191,073
-134,768
| -41% | -$4.71M |
|
3320
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$626M
| $5.97M | ﹤0.01% |
97,273
+87,865
| +934% | +$4.34M |
|
3321
CALL
Biohaven
BHVN
$2.33B
| $5.96M | ﹤0.01% |
248,100
-34,200
| -12% | -$1.21M |
|
3322
CALL
Vista Energy
VIST
$7.76B
| $5.96M | ﹤0.01% |
128,000
-313,000
| -71% | -$16.2M |
|
3323
JPMorgan BetaBuilders US Treasury Bond 1-3 Year ETF
BBSB
$55.1M
| $5.96M | ﹤0.01% |
+60,139
| New | +$5.92M |
|
3324
CALL
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.6B
| $5.96M | ﹤0.01% |
74,100
-155,700
| -68% | -$13.6M |
|
3325
Visteon
VC
$2.72B
| $5.95M | ﹤0.01% |
76,689
+28,477
| +59% | +$2.4M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.